---
title: Your Guide to a Smart Clinical Strategy
description: "Drug research has advanced in remarkable ways, but it’s still about the basics: ensuring safety, efficacy and compliance. That trio is no easy feat, but without a strong clinical strategy, even the most promising, safe and compliant drug can fail. Get your research in better strategic shape with this quick-start plan."
---
×
[](https://td2inc.com/)
[](https://td2inc.com/)
[Clinical](https://blog.td2inc.com/tag/clinical)
# Your Guide to a Smart Clinical Strategy
June 5, 2018
> Drug research has advanced in remarkable ways, but it’s still about the basics: ensuring safety, efficacy and compliance. That trio is no easy feat, but without a strong clinical strategy, even the most promising, safe and compliant drug can fail. Get your research in better strategic shape with this quick-start plan:
#### The 3 Prongs of Smart Clinical Strategy
No clinical strategy is complete without considering these factors:
**1) Know the Drug**
Before crafting a go-to-market plan, take time to fully understand the ins and outs of the project. Poke holes in the plan before the market does. Question everything: How does the drug work from a scientific perspective? What happens if everything goes right? What happens if everything goes wrong?
**2) Know the Disease**
You’ll also need to fully understand the genomic context of sensitivity for the targeted tumor. Find what makes the disease particularly vulnerable to the drug, and pounce on it. What’s the kill spot? What patient tumors have it? Craft a clear action plan to find patients with those genomic traits, and ensure they are enrolled in the trial.
**3) Know the Market**
It’s not just about what the market looks like now—it’s about what the market might become. Think opportunistically about the best way to execute on your New Drug Application strategy amidst a sea of competition, but never forget what the science supports.
By the end, you’ll have a strong strategy grounded in sound science and smart thinking—focus on identifying the context of vulnerability from preclinical data and patient observation, and then match the drug to that specific context.
#### Easy Ways to Think Strategically
Need help approaching concepts in a more strategic way? Try these tips:
**1) Build Checks and Balances**
Plan preclinical work with ample endpoints (and flexibility to change course mid-stream in real-time) to determine: if the drug works as expected, the role of potential biomarkers and the ideal patient population(s) that would benefit.
**2) Abandon Bias**
Be open to new things, like using community oncology clinics as research sites. They may not be your first choice, but they often have talented researchers and a strong enrollment history.
**3) Take New Tangents**
The science might take you unexpected places. Go with it, especially for indications. You might be surprised to find a partial or complete response where you didn’t think you would. Adapt in real-time to run with the evidence.
Ready to get started? If you’re not meeting your goals the way you’d like, we can help. We create custom-crafted, [proven clinical strategies](https://td2inc.com/the-quick-start-guide-to-clinical-strategy/) for our clients that are both actionable and differentiating.
- [Advancing Bone and Sarcoma Cancer Research Through Robust In Vivo Models](https://blog.td2inc.com/advancing-bone-and-sarcoma-cancer-research-through-robust-in-vivo-models)
- [How the FDA’s Plausible Mechanism Framework Signals the Future of Precision Oncology](https://blog.td2inc.com/how-the-fdas-plausible-mechanism-framework-signals-the-future-of-precision-oncology)
- [What Makes Radioligand Therapy IND Strategy Fundamentally Different?](https://blog.td2inc.com/what-makes-radioligand-therapy-ind-strategy-fundamentally-different)
- [Receptor Mediated Therapies in the Clinic: From Targeting to Impact](https://blog.td2inc.com/receptor-mediated-therapies-in-the-clinic)
- [A Translational Lens on Synergistic Cancer Therapy: Insights from Our Recent Case Study](https://blog.td2inc.com/a-translational-lens-on-synergistic-cancer-therapy-insights-from-our-recent-case-study)
- [Redesigning Preclinical Oncology: A Framework for Improving Clinical Translatability with AI, RECIST-Inspired Metrics, and Systems-Level Thinking](https://blog.td2inc.com/redesigning-preclinical-oncology)
[Clinical](https://blog.td2inc.com/tag/clinical)
[Clinical](https://blog.td2inc.com/tag/clinical)
### [How the FDA’s Plausible Mechanism Framework Signals the Future of Precision Oncology](https://blog.td2inc.com/how-the-fdas-plausible-mechanism-framework-signals-the-future-of-precision-oncology)
March 13, 2026
The FDA’s newly announced Plausible Mechanism Framework marks an important step toward aligning regulatory pathways with the realities of modern ...
[Read more +](https://blog.td2inc.com/how-the-fdas-plausible-mechanism-framework-signals-the-future-of-precision-oncology)
[Clinical](https://blog.td2inc.com/tag/clinical)
[Clinical](https://blog.td2inc.com/tag/clinical)
### [Radiopharmaceutical Dosing Under FDA’s New Spotlight: What You Should Know](https://blog.td2inc.com/radiopharmaceutical-dosing-under-fdas-new-spotlight-what-you-should-know)
August 27, 2025
The FDA has issued a new draft guidance titled “Oncology Therapeutic Radiopharmaceuticals: Dosage Optimization During Clinical Development.” This ...
[Read more +](https://blog.td2inc.com/radiopharmaceutical-dosing-under-fdas-new-spotlight-what-you-should-know)
[Clinical](https://blog.td2inc.com/tag/clinical)
[Clinical](https://blog.td2inc.com/tag/clinical)
### [Expanding Access to CART Therapies: TD2 Oncology Featured in SCRS inFocus](https://blog.td2inc.com/expanding-access-to-cart-therapies-td2-oncology-featured-in-scrs-infocus)
August 26, 2025
In June 2025, the FDA announced a major shift in regulatory guidance: the elimination of Risk Evaluation and Mitigation Strategy (REMS) requirements ...
[Read more +](https://blog.td2inc.com/expanding-access-to-cart-therapies-td2-oncology-featured-in-scrs-infocus)
[Clinical](https://blog.td2inc.com/tag/clinical)
[Clinical](https://blog.td2inc.com/tag/clinical)
### [The Thing About Theranostics…](https://blog.td2inc.com/the-thing-about-theranostics)
April 16, 2025
The landscape of oncology drug development is rapidly evolving, with personalized medicine taking center stage. At the heart of this revolution is ...
[Read more +](https://blog.td2inc.com/the-thing-about-theranostics)
### Get Started
## Contact Us Today!
If you’re looking for an expert team to guide your trial with efficiency in mind, we can help. As the creators of the Dynamic Trial, TD2 provides start-to-finish support with trial strategy, design and execution for faster go-to-market potential.
[Get Started Now](https://td2inc.com/contact-us/)
[](https://td2inc.com/)
Office
13208 E. Shea Blvd,
Suite 100
Scottsdale, AZ 85259
Phone
(602) 358-8300
Connect with us
-
-
© 2026 Translational Drug Development. All Rights Reserved. [Terms and Conditions](https://td2inc.com/terms-and-conditions) | [Privacy Policy](https://td2inc.com/privacy-policy)
```json
{
"@context" : "https://schema.org",
"@type" : "BlogPosting",
"author" : {
"@type" : "Person",
"name" : "TD2 Admin",
"url" : "https://blog.td2inc.com/author/td2-admin"
},
"dateModified" : "2024-05-13T10:49:02.159Z",
"datePublished" : "2018-06-05T16:23:00.000Z",
"headline" : "Your Guide to a Smart Clinical Strategy",
"mainEntityOfPage" : {
"@id" : "https://blog.td2inc.com/your-guide-to-a-smart-clinical-strategy",
"@type" : "WebPage"
},
"publisher" : {
"@type" : "Organization",
"logo" : {
"@type" : "ImageObject",
"url" : "https://blog.td2inc.com/hubfs/TD2-Oncology-01-2.png"
},
"name" : "Translational Drug Development"
}
}
```